COMMUNIQUÉS West-GlobeNewswire

Novartis' Xolair® confirms re-treatment efficacy in chronic spontaneous urticaria patients after treatment interruption
16/09/2017
OPTIMA Phase IIIb data re-confirm that almost two thirds of patients treated with Xolair 300 mg for 6 months are well-controlled[1] Should a treatment pause be necessary, data showed almost 90% of chronic spontaneous [...]
Sanofi and Regeneron Announce Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis
16/09/2017
Sanofi and Regeneron Announce Positive Study Results for Dupixent ® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis - Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European [...]
Sanofi et Regeneron annoncent les résultats positifs d'une étude consacrée à Dupixent® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère
16/09/2017
Sanofi et Regeneron annoncent les résultats positifs d'une étude consacrée à Dupixent ® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère - Présentation orale des résultats de l'étude de phase 3 [...]
Summit Therapeutics Announces Exercise of Underwriters' Over-Allotment Option
15/09/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Summit Therapeutics plc (" [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2017
15/09/2017
Communiqué de presse Villepinte, le 15 septembre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Shire Debuts MYDAYIS® and New Research at the 30th Annual Psych Congress
15/09/2017
Shire Debuts MYDAYIS ® and New Research at the 30 th Annual Psych Congress Lexington, MA - September 15, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) will share new Attention Deficit Hyperactivity Disorder (ADHD) research [...]
Tresiba® trial shows that people with type 2 diabetes who avoid severe hypoglycaemia have a reduced risk of death
15/09/2017
PR170915_EASD_Tresiba_UK This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Solon Eiendom ASA : Primary insider notification
15/09/2017
(Oslo, Norway, 14 September 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 25 373 shares in Solon Eiendom ASA at a price of NOK 17,5908. Following [...]
Skåne University Hospital Becomes First Clinic in Sweden To Use Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease
15/09/2017
Press release Malmö, September 15, 2017 Skåne University Hospital Becomes First Clinic in Sweden To Use Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease The company's roll-out program on track as [...]
FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017
15/09/2017
FIT Biotech Oy Company release September 15th, 2017 at 9:00 EET FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017 (unaudited) This company release is a summary of FIT Biotech's Half Year Financial [...]
Herantis Pharma receives Life Sciences Nordic Stars Award
15/09/2017
Herantis Pharma receives Life Sciences Nordic Stars Award Herantis Pharma Plc Press release 15 Sep 2017 at 8:30 am Herantis Pharma plc ("Herantis") received the Nordic Stars Award at the Nordic Life Sciences Days in [...]
Fagron NV: Disclosure of received notification
15/09/2017
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands) 1 , 15 September 2017 Disclosure of received notification Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in [...]
Santhera Receives Negative Opinion from the CHMP for its Marketing Authorization Application for Raxone® in DMD and Intends to Appeal this Opinion
15/09/2017
Liestal, Switzerland, September 15, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative [...]
Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic's Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer
14/09/2017
Conference call scheduled for 2:00 PM CEST / 8:00 AM EDT tomorrow, Friday, September 15 COPENHAGEN, Denmark, September 14, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that an independent Data [...]
AB Science annonce que le CHMP a adopté une opinion négative pour l'enregistrement du masitinib dans la mastocytose systémique indolente après réévaluation du dossier
14/09/2017
Paris, 14 septembre 2017, 18h30 AB Science annonce que le CHMP a adopté une opinion négative pour l'enregistrement du masitinib dans la mastocytose systémique indolente, après réévaluation du dossier AB Science SA (NYSE [...]
AB Science announces that CHMP adopted a negative opinion for masitinib marketing authorization in indolent systemic mastocytosis after reassessment
14/09/2017
Paris, 14 September 2017, 6.30pm AB Science announces that CHMP adopted a negative opinion for masitinib marketing authorization in indolent systemic mastocytosis after reassessment AB Science SA (NYSE Euronext - [...]
Guerbet annonce que Vectorio®, un dispositif médical innovant pour les procédures cTACE, a reçu le marquage CE
14/09/2017
Vectorio ® sera présenté lors des prochains congrès de radiologie Villepinte (France), le 14 septembre 2017 (18 heures CEST) - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour [...]
Guerbet Announces CE Mark for Vectorio®, An Innovative Medical Device for cTACE Procedures
14/09/2017
Vectorio ® will be presented at the upcoming radiology congresses Villepinte (France), September 14, 2017 (6:00 PM CEST) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical [...]
Nestlé acquires majority interest in Blue Bottle Coffee
14/09/2017
This press release is also available in Français (pdf) and Deutsch (pdf) ....................................... Vevey, 14 September 2017 Nestlé acquires majority interest in Blue Bottle Coffee Nestlé today announced [...]

Pages